Literature DB >> 1690950

Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.

M Z Wojtukiewicz1, L R Zacharski, V A Memoli, W Kisiel, B J Kudryk, S M Rousseau, D C Stump.   

Abstract

Immunohistochemical techniques applied to fresh frozen sections of metastatic malignant melanoma tissue revealed abundant fibrinogen (or fibrin I) in perivascular areas throughout the tumor connective tissue stroma. Fibrin was readily detected in a focal distribution in the connective tissue around nodules of viable tumor. Staining for D-dimer of cross-linked fibrin (using an antibody that cross-reacted with fragment D of fibrinogen) coincided with staining for fibrin. Diffuse staining of tumor cell bodies was observed for Factor X, and Factor XIII ("a" subunit) was detected in scattered areas of connective tissue throughout the tumors. Factor VII was not detected, and only rare tumor cells stained for tissue factor. These results support the concept that a tumor cell-associated, thrombin-generating pathway exists in situ in malignant melanoma tissue that includes Factor X but neither tissue factor nor Factor VII. By contrast, tumor cell staining was observed rarely for urokinase and to a variable extent for tissue plasminogen activator.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690950     DOI: 10.1093/ajcp/93.4.516

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Fibrinolytic activity of earthworms extract (G-90) on lysis of fibrin clots originated from the venous blood of patients with malignant tumors.

Authors:  T M Hrzenjak; M Popović; L Tiska-Rudman
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

3.  An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.

Authors:  Piia-Riitta Karhemo; Suvi Ravela; Marko Laakso; Ilja Ritamo; Olga Tatti; Selina Mäkinen; Steve Goodison; Ulf-Håkan Stenman; Erkki Hölttä; Sampsa Hautaniemi; Leena Valmu; Kaisa Lehti; Pirjo Laakkonen
Journal:  J Proteomics       Date:  2012-07-17       Impact factor: 4.044

Review 4.  Anticoagulation, ferrotoxicity and the future of translational lung cancer research.

Authors:  Leo R Zacharski
Journal:  Transl Lung Cancer Res       Date:  2016-06

Review 5.  The hemostatic system and angiogenesis in malignancy.

Authors:  M Z Wojtukiewicz; E Sierko; P Klement; J Rak
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

Review 6.  Treatment of cancer with anticoagulants: rationale in the treatment of melanoma.

Authors:  D L Ornstein; L R Zacharski
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

Review 7.  Tissue factor as a tumor procoagulant.

Authors:  L V Rao
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

Review 8.  The role of fibrin in tumor metastasis.

Authors:  V Costantini; L R Zacharski
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

9.  Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy.

Authors:  Marek Z Wojtukiewicz; Marta Mysliwiec; Elwira Matuszewska; Stanislaw Sulkowski; Lech Zimnoch; Barbara Politynska; Anna M Wojtukiewicz; Stephanie C Tucker; Kenneth V Honn
Journal:  Biomolecules       Date:  2021-04-29

10.  Heterogeneous Expression of Proangiogenic and Coagulation Proteins in Gliomas of Different Histopathological Grade.

Authors:  Marek Z Wojtukiewicz; Marta Mysliwiec; Elwira Matuszewska; Stanislaw Sulkowski; Lech Zimnoch; Barbara Politynska; Anna M Wojtukiewicz; Stephanie C Tucker; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  2021-03-31       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.